<DOC>
	<DOCNO>NCT02205892</DOCNO>
	<brief_summary>Double-blind , randomized,4-week small-scale clinical trial lupeol treatment inflammatory non-inflammatory acne lesion split face fashion</brief_summary>
	<brief_title>Clinical Study Topical Lupeol Acne</brief_title>
	<detailed_description>To investigate clinical efficacy tolerability lupeol treatment facial acne , conduct small-scale , randomize , double-blinded , split-face clinical trial course 4 week . Fifteen 16 enrolled patient complete study , affect area half patient 's face treat 2 % lupeol twice daily side face treat vehicle control . Clinical visit schedule baseline 2 4 week . The primary outcome study percent change inflammatory lesion ( papule , pustule , nodule ) 4 week . The secondary outcome percent change non-inflammatory lesion ( open close comedo ) change Leeds revise acne grade system score 4 week . Adverse event ( AEs ) define unintended harmful sign symptom ; assess patient ' self-reporting physician ' skin examination visit . Results analyze use intent treat ( ITT ) group . The per-protocol ( PP ) population consist 15 patient major protocol deviation . Last observation carry forward ( LOCF ) analysis use evaluate primary secondary outcome . ** Randomization blindness process ** At time initial presentation , evaluation acne severity perform use individual count inflammatory non-inflammatory acne lesion assessment Leeds revise acne grade system score . Then , patient randomly assign either left- right-sided lupeol application , side face assign vehicle-control application . A simple random allocation sequence create use computer-based random number generator block size 4 . All dermatologist participate outcome assessment , physician assistant manage trial enrollment administration , medical statistician analyze data , patient blind assignment . Randomization cod strictly secure safe administration office clinical research center data entry complete . The integrity blinding ensure packaging study- control product identical tube require third party ( investigator/evaluator ) dispense medication . In addition , topical agent identical color odor .</detailed_description>
	<mesh_term>Lupeol</mesh_term>
	<criteria>• Patients age 15 year age old clinically diagnose mild moderate acne vulgaris ( Leeds revise acne grade system score 27 ) • Known pregnancy lactation , medical illness might influence result study , previous history oral acne medication surgical procedure include laser treatment within 6 month topical medication within 4 week study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>natural product</keyword>
	<keyword>clinical trial</keyword>
</DOC>